Q-linea’s SEK 301 Million Shares Offering

Lindahl assisted Q-linea on the deal.

Q-linea AB (publ), a company listed on Nasdaq Stockholm that develops and delivers innovative solutions for the diagnosis of infectious diseases, has carried out a directed issue of shares raising the company gross proceeds of SEK 301 million.

ABG Sundal Collier, Carnegie Investment Bank and Kempen & Co acted Joint Bookrunners in connection with the directed issue.

The subscription price was determined through an accelerated book building procedure to SEK 137 per share, which corresponds to a discount of approximately 5.8 percent in relation to the closing price on Nasdaq Stockholm on June 10, 2021. A number of Swedish and international institutional investors and sector specialist investors participated in the directed issue.

Lindahl’s team consisted of Mattias Prage (Picture), Helena Lindbäck and Elsa Malmqvist.

Involved fees earner: Helena Lindbäck – Lindahl; Elsa Malmqvist – Lindahl; Mattias Prage – Lindahl;

Law Firms: Lindahl;

Clients: Q-linea AB;

Federica Tiefenthaler

Author: Federica Tiefenthaler